News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,687 Results
Type
Article (61328)
Company Profile (75)
Press Release (584284)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173954)
Career Advice (2730)
Deals (32452)
Drug Delivery (97)
Drug Development (76909)
Employer Resources (150)
FDA (14953)
Job Trends (13968)
News (305293)
Policy (28991)
Tag
Academia (2895)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (89)
Alliances (43224)
ALS (88)
Alzheimer's disease (1319)
Antibody-drug conjugate (ADC) (109)
Approvals (14969)
Artificial intelligence (262)
Autoimmune disease (23)
Automation (15)
Bankruptcy (292)
Best Places to Work (10935)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (56)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (274)
Cancer (2179)
Cardiovascular disease (164)
Career advice (2313)
Career pathing (33)
CAR-T (153)
Cell therapy (427)
Cervical cancer (20)
Clinical research (62534)
Collaboration (785)
Compensation (321)
Complete response letters (20)
COVID-19 (2573)
CRISPR (43)
C-suite (259)
Cystic fibrosis (100)
Data (2147)
Decentralized trials (2)
Denatured (25)
Depression (42)
Diabetes (252)
Diagnostics (6156)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60226)
Editorial (38)
Employer branding (18)
Employer resources (132)
Events (94548)
Executive appointments (760)
FDA (16193)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (745)
Gene editing (109)
Generative AI (20)
Gene therapy (298)
GLP-1 (664)
Government (4457)
Grass and pollen (6)
Guidances (56)
Healthcare (18254)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2706)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14806)
IRA (38)
Job creations (3419)
Job search strategy (1942)
Kidney cancer (10)
Labor market (30)
Layoffs (502)
Leadership (22)
Legal (6463)
Liver cancer (69)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (275)
MASH (62)
Medical device (12681)
Medtech (12686)
Mergers & acquisitions (18223)
Metabolic disorders (629)
Multiple sclerosis (78)
NASH (14)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1835)
NextGen: Class of 2025 (6382)
Non-profit (4329)
Now hiring (12)
Obesity (319)
Opinion (232)
Ovarian cancer (71)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (21)
Patents (234)
Patient recruitment (110)
Peanut (51)
People (59574)
Pharmaceutical (21)
Pharmacy benefit managers (15)
Phase I (19686)
Phase II (27594)
Phase III (20143)
Pipeline (1124)
Policy (124)
Postmarket research (2477)
Preclinical (8397)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (6001)
Recruiting (61)
Regulatory (20116)
Reports (33)
Research institute (2397)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (67)
Series A (130)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3348)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (25)
The Weekly (32)
Vaccines (661)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (143)
Last 7 days (790)
Last 30 days (2465)
Last 365 days (30551)
2025 (10037)
2024 (32318)
2023 (36382)
2022 (46664)
2021 (51607)
2020 (50830)
2019 (44839)
2018 (34123)
2017 (30753)
2016 (30099)
2015 (35497)
2014 (28438)
2013 (25011)
2012 (26296)
2011 (26544)
2010 (25004)
Location
Africa (871)
Alabama (54)
Alaska (6)
Arizona (170)
Arkansas (14)
Asia (38057)
Australia (6849)
California (5528)
Canada (1841)
China (485)
Colorado (247)
Connecticut (257)
Delaware (138)
Europe (88581)
Florida (846)
Georgia (198)
Idaho (56)
Illinois (548)
India (25)
Indiana (277)
Iowa (10)
Japan (152)
Kansas (95)
Kentucky (23)
Louisiana (10)
Maine (61)
Maryland (825)
Massachusetts (4003)
Michigan (221)
Minnesota (338)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1632)
New Mexico (29)
New York (1619)
North Carolina (963)
North Dakota (9)
Northern California (2397)
Ohio (193)
Oklahoma (15)
Oregon (36)
Pennsylvania (1229)
Puerto Rico (12)
Rhode Island (31)
South America (1176)
South Carolina (17)
South Dakota (1)
Southern California (2112)
Tennessee (95)
Texas (872)
United States (21186)
Utah (172)
Virginia (141)
Washington D.C. (49)
Washington State (510)
West Virginia (3)
Wisconsin (58)
645,687 Results for "university of houston".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
·
6 min read
·
Angela Gabriel
Press Releases
FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics - April 8, 2025
April 9, 2025
·
4 min read
Business
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
Castle Biosciences, Inc. today announced that, for the second year in a row, its chief financial officer, Frank Stokes, has been selected as a Top 25 CFO of Houston by TOP CFOs (formerly Finance & Investing).
April 10, 2024
·
2 min read
Genetown
SolasCure Selected for Innovate UK Global Incubator Programme in Houston
SOLASCURE Ltd, a biotechnology company developing a novel treatment to transform chronic wound care, announced it has been selected for Innovate UK’s Global Incubator Programme in Houston, US.
June 3, 2024
·
2 min read
Business
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute
Coya Therapeutics, Inc. announces the expansion of its research collaboration with the Houston Methodist Research Institute (“HMRI”) through a sponsored research agreement (SRA) covering multiple initiatives.
June 20, 2024
·
10 min read
Biotherapies Pavilion Back by Popular Demand at 2024 AABB Annual Meeting in Houston, Texas
The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce the return of the Biotherapies Pavilion at the 2024 AABB Annual Meeting, which will take place Oct. 19-22 in Houston, Texas.
June 25, 2024
·
2 min read
Press Releases
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm
January 22, 2025
·
6 min read
Lone Star Bio
AuraVax Therapeutics recognizes its academic collaborator at the University of Houston for address at Keystone Conference
AuraVax Therapeutics, Inc. today announced that their partners at the University of Houston presented data at Keystone Symposia: Vaccinology During and After COVID-19 taking place from September 17-20, 2023.
September 19, 2023
·
2 min read
Press Releases
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year
November 19, 2024
·
3 min read
Press Releases
AuraVax recognizes the University of Houston for publication on intranasal NanoSTING, a broad-spectrum host-directed therapeutic for respiratory viruses
July 31, 2024
·
2 min read
1 of 64,569
Next
